ClinicalTrials.Veeva

Menu
E

Enhancing Care Foundation | Durban International Clinical Trials Unit

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Tofacitinib
MK-1242
Pretomanid
Vericiguat
BPaMZ
Bedaquiline
TBAJ876
MK-1242-035
Ensovibep
Linezolid

Parent organization

This site is a part of Enhancing Care Foundation

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 6 total trials

A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035) (VICTOR)

The purpose of this study is to evaluate the efficacy and safety of vericiguat in participants with chronic heart failure with reduced ejection fract...

Active, not recruiting
Chronic Heart Failure With Reduced Ejection Fraction
Drug: Vericiguat
Drug: Placebo

Evaluate long-term safety and tolerability of tofacitinib in patients with JIA, who have previously participated in tofacitinib JIA studies.

Active, not recruiting
Juvenile Idiopathic Arthritis
Drug: Tofacitinib

Trial sponsors

Pfizer logo
G
Merck Sharp & Dohme (MSD) logo
Novartis logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems